Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine infusion for pediatric tonsillectomy and adenoidectomy
NCT03902314Phase 4Completed
- Sponsor
- Rhode Island Hospital
- Start
- May 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, sponsored by Rhode Island Hospital. Primary endpoint: Change in Pain Scores at 120 months. Started May 2019; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03902314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03902314.